- Home
- PET vs CRIS Comparison
PET vs CRIS Comparison
Compare PET & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- CRIS
- Stock Information
- Founded
- PET 2015
- CRIS 2000
- Country
- PET United States
- CRIS United States
- Employees
- PET N/A
- CRIS N/A
- Industry
- PET EDP Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PET Technology
- CRIS Health Care
- Exchange
- PET Nasdaq
- CRIS Nasdaq
- Market Cap
- PET 40.4M
- CRIS 37.4M
- IPO Year
- PET N/A
- CRIS 2000
- Fundamental
- Price
- PET $0.86
- CRIS $4.98
- Analyst Decision
- PET Strong Buy
- CRIS Strong Buy
- Analyst Count
- PET 5
- CRIS 4
- Target Price
- PET $4.40
- CRIS $37.33
- AVG Volume (30 Days)
- PET 152.4K
- CRIS 78.4K
- Earning Date
- PET 08-07-2024
- CRIS 10-31-2024
- Dividend Yield
- PET N/A
- CRIS N/A
- EPS Growth
- PET N/A
- CRIS N/A
- EPS
- PET N/A
- CRIS N/A
- Revenue
- PET $85,343,000.00
- CRIS $10,161,000.00
- Revenue This Year
- PET $9.11
- CRIS $5.86
- Revenue Next Year
- PET $14.58
- CRIS $5.49
- P/E Ratio
- PET N/A
- CRIS N/A
- Revenue Growth
- PET 17.14
- CRIS N/A
- 52 Week Low
- PET $0.66
- CRIS $0.38
- 52 Week High
- PET $2.47
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- PET 39.05
- CRIS 41.18
- Support Level
- PET $0.78
- CRIS $4.76
- Resistance Level
- PET $0.87
- CRIS $8.29
- Average True Range (ATR)
- PET 0.07
- CRIS 0.72
- MACD
- PET 0.02
- CRIS 0.03
- Stochastic Oscillator
- PET 81.97
- CRIS 20.62
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools, and pet wellness plans.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.